Shopping Cart 0
Cart Subtotal
USD 0

WuXi NextCODE Genomics - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

WuXi NextCODE Genomics USA Inc (WuXi NextCODE), a subsidiary of Wuxi Pharmatech (Cayman) Inc, is a genomic information company that offers competencies in generating, organizing, mining, sharing and applying genomic data. The company develops gene sequence analysis platform and database architecture, which enables clinicians and researchers across the globe to use the power of next-generation sequencing data to better diagnose and treat diseases. WuXi NextCODE's services comprise genome analysis and interpretation, big data management and storage, custom integration and next generation sequencing. It has operations in Shanghai, Cambridge and Reykjavik. WuXi NextCODE is headquartered in Cambridge, Massachusetts, the US.

WuXi NextCODE Genomics-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

WuXi NextCODE Genomics, Medical Equipment Deals By Type, 2012 to YTD 2018 7

WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

WuXi NextCODE Genomics, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

WuXi NextCODE Genomics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

WuXi NextCODE Genomics, Medical Equipment, Deal Details 12

Venture Financing 12

DNAnexus Raises USD58 Million in Equity Financing 12

WuXi NextCODE Raises Additional USD165 Million in Series B Financing 14

WuXi NextCODE Raises USD75 Million in Series B Financing 15

Claritas Genomics Raises USD15 Million in Series B Financing 16

NextCode Health Raises USD15 Million in Series A Financing 18

Partnerships 19

WuXi NextCode Enters into Partnership with Rhythm Pharma 19

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 20

Genomics England Enters into Contract Agreement with WuXi NextCODE 21

SA1KCGP, WuXi NextCODE and START Enter into Partnership 22

WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 23

WuXi NextCODE Enters into Agreement with Children's Hospital of Fudan University 24

WuXi NextCODE and DNAnexus Enter into Partnership 25

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 26

Acquisition 27

WuXi PharmaTech Acquires NextCODE Health for USD65 Million 27

WuXi NextCODE Genomics-Key Competitors 28

WuXi NextCODE Genomics-Key Employees 29

WuXi NextCODE Genomics-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Strategy And Business Planning 31

Jan 09, 2017: AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance 31

Corporate Communications 32

Apr 15, 2018: WuXi NextCODE Appoints Richard Williams As Managing Director And Head Of Oncology Programs 32

Mar 12, 2018: WuXi NextCODE Appoints Rob Brainin As Chief Executive Officer 33

Jan 18, 2018: Wuxi NextCODE Appoints Accomplished Life Sciences Senior Executive Louis Yuan as China General Manager 34

Dec 14, 2017: Dr. Christina Waters Joins Wuxi Nextcode Team to Expand Reach and Impact of the Global Platform for Rare Disease 35

Nov 09, 2017: WuXi NextCODE Appoints Baidu Veteran John Gu to Drive Growth of Genomic Data Platform in China 36

Feb 28, 2017: WuXi NextCODE Appoints Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as COO 37

Feb 20, 2017: WuXi NextCODE Named One of Fast Company's Top 10 Most Innovative Companies in Biotech for Providing the World's Leading Platform for Genomic Data 38

Government and Public Interest 39

Feb 28, 2017: China plans leading role in 'precision medicine' field 39

Product News 40

Oct 17, 2017: WuXi NextCODE ASHG: Population Genomics, Unleashing Cancer Data, Diagnosing Rare Disease, the Internet of DNA 40

May 15, 2017: WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease and Cancer in Yale Nature study 41

Other Significant Developments 42

Apr 26, 2018: WuXi NextCODE: Introducing an Internet of DNA for Solving Rare Disease 42

Mar 07, 2018: WuXi NextCODE Unveils Genomics Partnership with Google Cloud 43

Feb 12, 2018: 10x Genomics Announces New Partnership Programs 44

Jan 09, 2018: WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity 45

Oct 17, 2017: WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data 46

Feb 08, 2017: Geneformics Selected by WuXi NextCODE to Reduce Data Footprint of Massive, Global Genomics Data 47

Jan 05, 2017: WuXi NextCODE Selected as Genomics Platform for Singapore Precision Medicine Effort 48

Appendix 49

Methodology 49

About GlobalData 49

Contact Us 49

Disclaimer 49


List Of Figure

List of Figures

WuXi NextCODE Genomics, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

WuXi NextCODE Genomics, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

WuXi NextCODE Genomics, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

WuXi NextCODE Genomics, Medical Equipment, Key Facts 2

WuXi NextCODE Genomics, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

WuXi NextCODE Genomics, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

WuXi NextCODE Genomics, Medical Equipment Deals By Type, 2012 to YTD 2018 7

WuXi NextCODE Genomics, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

WuXi NextCODE Genomics, Deals By Market, 2012 to YTD 2018 9

WuXi NextCODE Genomics, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

DNAnexus Raises USD58 Million in Equity Financing 12

WuXi NextCODE Raises Additional USD165 Million in Series B Financing 14

WuXi NextCODE Raises USD75 Million in Series B Financing 15

Claritas Genomics Raises USD15 Million in Series B Financing 16

NextCode Health Raises USD15 Million in Series A Financing 18

WuXi NextCode Enters into Partnership with Rhythm Pharma 19

AbbVie Enters into Agreement with Genomics Medicine Ireland and WuXi NextCODE Genomics 20

Genomics England Enters into Contract Agreement with WuXi NextCODE 21

SA1KCGP, WuXi NextCODE and START Enter into Partnership 22

WuXi NextCODE Genomics Enters into Agreement with Sidra Medical and Research Center 23

WuXi NextCODE Enters into Agreement with Children's Hospital of Fudan University 24

WuXi NextCODE and DNAnexus Enter into Partnership 25

NextCode Health Enters into Licensing Agreement with deCode Genetics for Clinical Diagnostics 26

WuXi PharmaTech Acquires NextCODE Health for USD65 Million 27

WuXi NextCODE Genomics, Key Competitors 28

WuXi NextCODE Genomics, Key Employees 29

WuXi NextCODE Genomics, Other Locations 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

WuXi NextCODE Genomics, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.